Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnoCare PharmaINCPF 83 Days Inventory is 222.04 as of Dec. 2025, which is 9% below its 10-year median of 243.74. GuruFocus rates INCPF with a GF Score™ of 83/100 and a GF Value™ of $2.32. The stock has 7 warning signs investors should review. Among 640 Biotechnology companies, InnoCare Pharma ranks worse than 60.16% on this metric.
The historical rank and industry rank for InnoCare Pharma's Days Inventory or its related term are showing as below:
INCPF'
s Days Inventory Range Over the Past 10 Years
Min: 32.62 Med: 243.74 Max: 286.83
Current: 237.67
During the past 9 years, InnoCare Pharma's highest Days Inventory was 286.83. The lowest was 32.62. And the median was 243.74.
INCPF's Days Inventory is ranked worse than 60.16% of 640
companies
in the Biotechnology industry
Industry Median: 183.75
vs INCPF: 237.67
InnoCare Pharma's Days Inventory
declined
from Dec. 2024 (249.85) to Dec. 2025 (222.04).
Inventory Turnover measures how fast the company turns over its inventory within a year.
InnoCare Pharma's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.82.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
InnoCare Pharma's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.08.
InnoCare Pharma (OTCPK:INCPF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
InnoCare Pharma's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
InnoCare Pharma's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
InnoCare Pharma Days Inventory Related Terms
InnoCare Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for InnoCare Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INCPF vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, InnoCare Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCare Pharma Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, InnoCare Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where InnoCare Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnoCare Pharma (INCPF) has a Days Inventory of 222.04 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on InnoCare Pharma and its competitors. This is near median its historical median of 243.74. Over the past decade, InnoCare Pharma's Days Inventory has ranged from 32.62 to 286.83. According to the industry distribution chart, InnoCare Pharma ranks #385 out of 640 companies in the Biotechnology industry, placing it in the top 60.2%.
Is InnoCare Pharma's Days Inventory too high?
InnoCare Pharma's current Days Inventory of 222.04 is near median its 10-year median of 243.74. Over the past 10 years, this metric has ranged from a low of 32.62 to a high of 286.83. The Biotechnology industry median Days Inventory is 183.75. InnoCare Pharma's value of 222.04 is 20.8% above this industry median. Based on the distribution chart, InnoCare Pharma ranks #385 out of 640 companies in the Biotechnology industry, which is below the industry midpoint. Overall, InnoCare Pharma has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does InnoCare Pharma's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, InnoCare Pharma ranks #385 out of 640 companies for Days Inventory. This places InnoCare Pharma in the lower half of its industry. The industry median Days Inventory is 183.75. InnoCare Pharma's value of 222.04 is 20.8% above this benchmark. Historically, InnoCare Pharma's own Days Inventory has ranged from 32.62 to 286.83 over the past decade. While the company's 10-year median is 243.74 vs. the industry median of 183.75, InnoCare Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.75, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCare Pharma's current Days Inventory of 222.04 is 20.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on InnoCare Pharma and its competitors. For the Biotechnology industry, the median Days Inventory is 183.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCare Pharma's current Days Inventory is 222.04, which is near median its own 10-year median of 243.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Pharma stock overvalued right now?
InnoCare Pharma (INCPF) has a current Days Inventory of 222.04. The stock's GF Value™ is $2.32, compared to a current price of $1.55 — trading 33.2% below its estimated fair value. The current Days Inventory is 222.04, which is near median its 10-year median of 243.74 and 20.8% above the Biotechnology industry median of 183.75. InnoCare Pharma's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For InnoCare Pharma (INCPF), the current Days Inventory is 222.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCare Pharma (INCPF) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCare Pharma stock appears to be undervalued.
The current stock price of $1.55 is trading 33.2% below its estimated GF Value™ of $2.32.
Key valuation signals for INCPF:
Days Inventory: 222.04 (near median its 10-year median of 243.74)
GF Value™: $2.32 vs. price of $1.55 (33.2% below fair value)
Industry Position: 20.8% above the Biotechnology median (#385 of 640)
No single metric tells the full story. See the INCPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.
83GF Score
Get the complete analysis for INCPF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INCPF has been successfully added to your 
